HALO — Halozyme Therapeutics, Inc.
7 mentions in the last 24 hours · 0.02% of all mentions
Why people talked about HALO (2026-11-06)
- Halozyme Therapeutics reported Q3 2026 earnings that beat EPS estimates by $0.09.
- The company released a press announcement regarding financial results for the quarter ended September 30, 2026.
- Revenue reached $493.0M, exceeding estimates by $3.6M with 39.15% year-over-year growth.
| Bluesky | 2 | community |
| GDELT | 2 | news |
| Marketaux | 1 | news |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |